Clinical trials in special patient populations webinar is now available

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Photogestoeber)
(Image: Getty/Photogestoeber)

Related tags: special patient populations

Outsourcing-Pharma’s webinar on special patient populations happened this week but you still have the chance to catch-up on the discussions on demand.

Regulatory agencies require that clinical trial sponsors are able to present a summary of safety and efficacy data organized by demographic subgroups, such as age, gender and ethnicity.

In Outsourcing-Pharma’s latest webinar, which can still be accessed through the registration page​, we held a discussion on the key enablers of inclusive clinical research and how there is more that still needs to be done to ensure population demographics are fairly represented in clinical trials.

The discussion featured Annemarie Forest​, director of projects at the Clinical trials Transformation Initiative (CTTI), Christina Brennan​, VP of clinical research at The Feinstein institutes for Medical Research, and Jasmine Benger, ​senior project manger of research services at the Center for information and Study of Clinical Research Participation.

During the course of the webinar, the discussion covered the following areas:

  • Clinical trial participation and the factors affecting this
  • How the differing ages of potential participants may impact their view of trials
  • Including the patient throughout the clinical trial process
  • How to improve patient diversity and what changes have occurred in recent years
  • How technology and the generation of real-world data could improve participation

In addition to these talking points and others offered by our speakers, questions from our audience were also addressed. You can view the entire webinar on demand for free through this link​.

The webinar was enabled through the participation of our sponsors, Capsugel by Lonza Pharma & Biotech, Marken, QPS, and Synteract.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars